fda semaglutide shortage resolved 2025 announcement Bad news: You may get cut off from your GLP-1 this week… Semaglutide Market Size, Share &

PlexusDx offers both options, and your provider can recommend based on your health history and genetic profile

When discussing microdosing with your provider, be specific about why you want a sub-standard starting dose

Users dealing with gut issues including leaky gut syndrome , gastritis, or intestinal inflammation might find immediate release formulations appropriate

Clinical Efficacy and Weight Reduction Outcomes Over 68 weeks, obese people who are not diabetic who take 2.4 mg of semaglutide every week regularly lose 15 to 17 percent of their body weight

Because the Wegovy pill is a protein-based medication, it is fragile

PlexusDx supports precision-wellness by offering biomarker and genetic context to inform conversations with healthcare providers about whether compounded GLP-1 options align with individual IBS presentation